Category Archives: News

AstraZeneca, Merck's Lynparza plows ahead in ovarian cancer with $1B-plus approval, phase 3 data

The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »

LifeBridge Health faces class-action lawsuit stemming from massive cyberbreach in 2016

Law firm Murphy, Falcon & Murphy has filed a statewide class action lawsuit against Baltimore provider LifeBridge Health on behalf of more than 530,000 consumers whose personal information including Social Security numbers, birth dates, names, addresses, health insurance information, client treatment information, and medical diagnoses were stolen. The data breach occurred on or about September… Read More »